Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Valproic Acid on Estetrol/Drospirenone PK
NCT03512860Phase 1Completed
- Sponsor
- Estetra SRL
- Start
- Apr 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of estetrol and drospirenone in contraception (2 arms), sponsored by Estetra SRL. Primary endpoints: Maximum concentration of Estetrol, Area under the curve to last determined concentration of Estetrol and 1 more. Started Apr 2018; status: completed.
02
Drugs
estetroldrospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03512860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03512860.